MAGL inhibition was shown to exert antitumor effects in several cancer cell lines [16,177]; however, the inhibition of MAGL may also cause neurodegenerative, inflammatory and metabolic side effects [178] (Figure 7). The gene discussed is MGLL; the disease is cancer.